Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 -0.04 (-3.39%)
As of: Sep 29, 2026 · 3:59 PM EDT

Actinium Pharmaceuticals (ATNM) Non-Current Debt (2010 - 2012)

Updated

Actinium Pharmaceuticals (ATNM) recorded Non-Current Debt of $72,857 in Q4 2012.

Analysis

Actinium Pharmaceuticals (ATNM) Non-Current Debt (2010 - 2012) Analysis & Trends

Starting with Q4 2010, Actinium Pharmaceuticals' Non-Current Debt history includes 6 quarters.

  • Across earlier years, Non-Current Debt came in at $58,168 in FY2011 (-0.9%) and $58,707 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 72,857.00
Jun 30, 2012 71,260.00
Mar 31, 2012 64,173.00
Dec 31, 2011 58,168.00
Sep 30, 2011 53,753.00
Jun 30, 2011 53,753.00
Dec 31, 2010 58,707.00
API Access

Actinium Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ATNM&period=max&api_key=YOUR_API_KEY